Clinical Trials
40 trialsPediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
BWHS RoR
Boston University
FIMBRIECTOMIE
Centre Oscar Lambret
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
M.D. Anderson Cancer Center
Identifying and Caring for Individuals With Inherited Cancer Syndrome
OHSU Knight Cancer Institute
Sequential EHR Based Interventions to Increase Genetic Testing for Breast and Ovarian Cancer Predisposition
Abramson Cancer Center at Penn Medicine
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
M.D. Anderson Cancer Center
Reborn-i
Beaumont Hospital
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
Georgetown University
CHARM
Kaiser Permanente
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Georgetown University
Women at Risk of Breast Cancer and OLFM4
Institut Cancerologie de l'Ouest
PC-CDS
HealthPartners Institute
Clinical Impact of Enhanced Risk Assessments in Women With a BRCA1/2 Mutation, CARE Study
Ohio State University Comprehensive Cancer Center
TUMOSPEC
UNICANCER
DIRECT
Umeå University
LIBER
UNICANCER
LIBRE
Technical University of Munich
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Washington University School of Medicine
LIBRE-2
Technical University of Munich
Nutritional Intervention and DNA Damage of Patients With HBOC
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer
National Institutes of Health Clinical Center (CC)
Enhance the Use of Genetic Counseling and Testing in Latinas
Georgetown University
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Georgetown University
Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC Risk
Centre Jean Perrin
Statewide Communication to Reach Diverse Low Income Women
University of California, San Francisco
Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
GOG Foundation
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Georgetown University
Genetic Counseling for Breast Cancer Survivors (GC for BC)
H. Lee Moffitt Cancer Center and Research Institute
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Sheba Medical Center
Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy
National Cancer Institute (NCI)
Risk-Reducing Surgeries for Hereditary Ovarian Cancer
Peking Union Medical College Hospital
Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children
Georgetown University
Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study
Medical University of Vienna
Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
National Cancer Institute (NCI)
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Sheba Medical Center
Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast Cancer
National Cancer Institute (NCI)
EXSAL
Centre Francois Baclesse
Telemedicine vs. Face-to-Face Cancer Genetic Counseling
Duke University
Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
The Cleveland Clinic